Meilin Wang

This paper develops a dual-targeting compound that eliminates regulatory B cells and overcomes STING resistance in pancreatic cancer, improving immunotherapy outcomes.

This study improves polygenic risk scores for colorectal cancer by combining Asian and European ancestry data, enhancing risk prediction across diverse racial and ethnic groups.

This paper introduces a deep learning model to improve GWAS by detecting complex genetic effects, revealing potential causal pathways in disease development.